Table 1 Patient characteristics and pathological findings in two groups
Characteristics | Growing group (n = 54) | Stable group (n = 62) | p values |
|---|---|---|---|
Age‡ | 63.41 ± 9.03 | 53.77 ± 10.54 | < 0.001 |
Smoking history | 0.038 | ||
No | 34(63.0%) | 50(80.6%) | |
Yes | 20(37.0%) | 12(19.4%) | |
Tumor history | 0.753 | ||
No | 48(88.9%) | 57(91.9%) | |
Yes | 6(11.1%) | 5(8.1%) | |
Gender | 0.061 | ||
Female | 25(46.3%) | 40(64.5%) | |
Male | 29(53.7%) | 22(35.5%) | |
Invasive | < 0.001 | ||
No | 27(50.0%) | 57(91.9%) | |
Yes | 27(50.0%) | 5(8.1%) | |
Surgical history | 0.028 | ||
No | 31(57.4%) | 48(77.4%) | |
Yes | 23(42.6%) | 14(22.6%) | |
Initial Size(mm) | 0.428 | ||
< 8 | 18(33.3%) | 23(37.1%) | |
8–10 | 10(18.5%) | 17(27.4%) | |
10–15 | 15(27.8%) | 15(24.2%) | |
> 15 | 11(20.4%) | 7(11.3%) | |
Follow up duration (months) | 0.121 | ||
< 12 | 14(25.9%) | 25(40.3%) | |
12–24 | 12(22.2%) | 17(27.4%) | |
24–36 | 14(25.9%) | 13(21.0%) | |
> 36 | 14(25.9%) | 7(11.3%) | |
Stage | < 0.001 | ||
0 | 8(14.8%) | 39(62.9%) | |
Ia1 | 17(31.5%) | 17(27.4%) | |
Ia2 | 18(33.3%) | 5(8.1%) | |
Ia3 | 8(14.8%) | 1(1.6%) | |
Ib | 3(5.6%) | 0(0%) |